AU2001271887A1 - Methods for diagnosis and treatment of psychiatric disorders - Google Patents

Methods for diagnosis and treatment of psychiatric disorders

Info

Publication number
AU2001271887A1
AU2001271887A1 AU2001271887A AU7188701A AU2001271887A1 AU 2001271887 A1 AU2001271887 A1 AU 2001271887A1 AU 2001271887 A AU2001271887 A AU 2001271887A AU 7188701 A AU7188701 A AU 7188701A AU 2001271887 A1 AU2001271887 A1 AU 2001271887A1
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
methods
psychiatric disorders
psychiatric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271887A
Inventor
Thomas B. Barrett
John R. Kelsoe Jr.
Alexander B. Niculescu Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2001271887A1 publication Critical patent/AU2001271887A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
AU2001271887A 2000-07-06 2001-07-06 Methods for diagnosis and treatment of psychiatric disorders Abandoned AU2001271887A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21626300P 2000-07-06 2000-07-06
US60/216,263 2000-07-06
PCT/US2001/021453 WO2002004677A2 (en) 2000-07-06 2001-07-06 Methods for diagnosis and treatment of psychiatric disorders

Publications (1)

Publication Number Publication Date
AU2001271887A1 true AU2001271887A1 (en) 2002-01-21

Family

ID=22806394

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271887A Abandoned AU2001271887A1 (en) 2000-07-06 2001-07-06 Methods for diagnosis and treatment of psychiatric disorders

Country Status (5)

Country Link
US (1) US7488576B2 (en)
EP (1) EP1366183A2 (en)
AU (1) AU2001271887A1 (en)
CA (1) CA2414403A1 (en)
WO (1) WO2002004677A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096264A1 (en) * 2001-06-18 2003-05-22 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (MPHTS)
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
WO2006013561A2 (en) * 2004-08-02 2006-02-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions and methods for diagnosing and treating post traumatic stress disorder
US7906281B2 (en) * 2005-10-07 2011-03-15 The Regents Of The University Of California Method to predict the response to lithium treatment
WO2007047634A2 (en) * 2005-10-14 2007-04-26 The Regents Of The University Of California Method to diagnose, predict treatment response and develop treatments for psychiatric disorders using markers
GB0524110D0 (en) * 2005-11-28 2006-01-04 Univ Cambridge Tech Biomarkers and methods for identification of agents useful in the treatment of affective disorders
AU2006320633A1 (en) * 2005-11-29 2007-06-07 Children's Hospital Medical Center Optimization and individualization of medication selection and dosing
GB2449819A (en) * 2006-02-28 2008-12-03 Univ California Genes differentially expressed in bipolar disorder and/or schizophrenia
TW200806284A (en) * 2006-03-31 2008-02-01 Alcon Mfg Ltd Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
WO2008045687A2 (en) * 2006-10-11 2008-04-17 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods for detecting and treating attention-deficit/hyperactivity disorder (adhd)
WO2008094125A1 (en) * 2007-02-02 2008-08-07 Nanyang Polytechnic Method and system for automatic psychiatric disorder detection and classification
WO2008144613A1 (en) * 2007-05-17 2008-11-27 The University Of North Carolina At Chapel Hill Biomarkers for the diagnosis and assessment of bipolar disorder
US20100233702A1 (en) * 2007-10-04 2010-09-16 The Regents Of The University Of California Method to predict response to treatment for psychiatric illnesses
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US20230374590A1 (en) * 2021-09-14 2023-11-23 Massachusetts Institute Of Technology Methods and reagent for diagnosing bipolar disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
WO2000050436A1 (en) * 1999-02-23 2000-08-31 Genaissance Pharmaceuticals, Inc. Receptor isogenes: polymorphisms in the tissue necrosis factor receptor

Also Published As

Publication number Publication date
WO2002004677A2 (en) 2002-01-17
EP1366183A2 (en) 2003-12-03
CA2414403A1 (en) 2002-01-17
US20040053257A1 (en) 2004-03-18
US7488576B2 (en) 2009-02-10
WO2002004677A8 (en) 2003-12-11
WO2002004677A3 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2003286567A1 (en) Methods for the treatment of skin disorders
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU6910600A (en) Methods for the treatment of mental disorders
AU2001286983A1 (en) Method of treatment
AU3784999A (en) Methods for treatment of pain
AU2002246490A1 (en) Method of treating parkinson's disease
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU7106300A (en) Treatment of skin disorders
AU3757300A (en) Method of treating anxiety disorders
AU2080201A (en) Treatment of addiction disorders
IL152782A0 (en) S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
AU3899100A (en) Treatment of hyperactivity disorders
AU2566201A (en) Compounds and methods for the treatment of pain
AU2001262177A1 (en) Method of treatment
AU2001253560A1 (en) Methods of treatment
AU2002348324A1 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 46566